Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 3/20 | 0.45 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.41 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.37 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | MPL | P40238 | 1/20 | 0.37 |
| ▸ | CTSS | P25774 | 1/20 | 0.36 |
| ▸ | DHODH | Q02127 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | AXL | P30530 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28723095 | 0.98 | HSD11B1 (0.44) | HSD11B1TAS2R14NOTUMCHRM3ACHE | |
| SCHEMBL6630838 | 0.85 | TAS2R14 (0.46) | HSD11B1TAS2R14NOTUMP2RX7SMN1; SMN2 | |
| SCHEMBL10080312 | 0.84 | CHRM3 (0.38) | HSD11B1TAS2R14CHRM3ACHESLC22A12 | |
| SCHEMBL26375361 | 0.81 | HSD11B1 (0.50) | HSD11B1TAS2R14NOTUMACHEMPL | |
| SCHEMBL8254661 | 0.81 | CA2 (0.46) | HSD11B1CHRM3ACHESMN1; SMN2TRPA1 | |
| SCHEMBL19585261 | 0.78 | KIF11 (0.36) | HSD11B1TAS2R14MPLKIF11 | |
| SCHEMBL3821590 | 0.78 | TRPA1 (0.48) | HSD11B1TAS2R14NOTUMACHEP2RX7 | |
| SCHEMBL30867018 | 0.78 | TRPA1 (0.48) | HSD11B1TAS2R14NOTUMACHEP2RX7 | |
| SCHEMBL23886300 | 0.77 | CHRM3 (0.37) | HSD11B1CHRM3ACHESMN1; SMN2MPL | |
| SCHEMBL11955140 | 0.76 | CA2 (0.46) | HSD11B1TAS2R14NOTUMP2RX7CTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4400172-A2 | PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS | Incyte Holdings Corporation (US) | 2024-07-17 | — | — | EP | disclosed |
| WO-2024015251-A1 | INHIBITORS OF HPK1 AND METHODS OF USE THEREOF | ARCUS BIOSCIENCES, INC. (US) | 2024-01-18 | — | — | WO | disclosed |
| WO-2023220741-A1 | ALPHA 4 BETA 7 INTEGRIN MODULATORS AND USES THEREOF | DICE MOLECULES SV, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| EP-4273147-A1 | SUBSTITUTED SPIROLACTAMS, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | Bayer Aktiengesellschaft (DE) | 2023-11-08 | — | — | EP | disclosed |
| US-20230309388-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-09-28 | — | — | US | disclosed |
| US-20230271943-A1 | COMPOUNDS AS DHODH INHIBITORS | NANJING ZENSHINE PHARMACEUTICALS CO., LTD. (CN) | 2023-08-31 | — | — | US | disclosed |
| US-20230271943-A1 | COMPOUNDS AS DHODH INHIBITORS | NANJING ZENSHINE PHARMACEUTICALS CO., LTD. (CN) | 2023-08-31 | — | — | US | disclosed |
| EP-3611165-B1 | PYRIDONE COMPOUND, AND AGRICULTURAL AND HORTICULTURAL FUNGICIDE HAVING THIS AS ACTIVE COMPONENT | MITSUI CHEMICALS CROP & LIFE SOLUTIONS INC (JP) | 2023-08-16 | — | — | EP | disclosed |
| US-11664093-B2 | Extrapolative prediction of enantioselectivity enabled by computer-driven workflow, new molecular representations and machine learning | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2023-05-30 | — | — | US | disclosed |
| US-11634445-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-04-25 | — | — | US | disclosed |
| US-6048986-A | DEHYDRATION OF DIFLUOROPYROMELLITIC ACID TO FORM DIFLUOROPYROMELLITIC DIANHYDRIDE | NIPPON TELEGRAPH AND TELEPHONE CORP. (JP) | 2000-04-11 | — | — | US | disclosed |
| US-5849934-A | Method for preparing aromatic compounds | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 1998-12-15 | — | — | US | disclosed |
| US-5750731-A | POLYIMIDE ANHYDRIDE MONOMERS | NIPPON TELEGRAPH & TELEPHONE CORPORATION (JP) | 1998-05-12 | — | — | US | disclosed |
| EP-0480266-B1 | Perfluorinated polyimide, perfluorinated poly(amic acid), starting compounds therefor, and methods for preparing them | NIPPON TELEGRAPH & TELEPHONE (JP) | 1996-06-26 | — | — | EP | disclosed |
| US-5449741-A | Electronics with impact strength | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 1995-09-12 | — | — | US | disclosed |
| US-5336670-A | 2,2-dimethyl-3-(but-1-en-3-ynyl)-cyclopropane carboxylates | ROUSSEL-UCLAF (FR) | 1994-08-09 | — | — | US | disclosed |
| US-5233018-A | Heat resistance and low optical transmission loss in the near-infrared region; integrated circuits | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 1993-08-03 | — | — | US | disclosed |
| EP-0480266-A2 | Perfluorinated polyimide, perfluorinated poly(amic acid), starting compounds therefor, and methods for preparing them | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 1992-04-15 | — | — | EP | disclosed |
| US-4141912-A | Process for the preparation of polyhalobenzylic disulfooxonium compounds | HOOKER CHEMICALS & PLASTICS CORP. (US) | 1979-02-27 | — | — | US | disclosed |
| US-4075238-A | Polyhalobenzylic disulfooxonium compounds | HOOKER CHEMICALS & PLASTICS CORPORATION (US) | 1978-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230271943-A1 | COMPOUNDS AS DHODH INHIBITORS | DHODH, DLD, DHRS9 | HSD11B1 50/4885TAS2R14 3025/4885NOTUM 686/4885 |
| US-20230309388-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE | OCIAD1, OCIAD2, SLCO4C1 | HSD11B1 608/4885TAS2R14 2752/4885NOTUM 2913/4885 |
| US-11634445-B2 | Organic electroluminescent materials and devices | L1CAM, EPCAM, SOD1 | HSD11B1 4676/4885TAS2R14 1535/4885NOTUM 3877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.